Key questions: Can the mega-combination truly achieve mega-savings? And if so, how much of those synergies will be shared with downstream customers?
A few years ago, Express Scripts, Kroger, and Supervalu formed Econdisc Contracting Solutions, a group purchasing organization for generics. Expect more cross-company buying deals as drug channels participants position for our generic future.
Here is Lazard’s list:
Per Lazard, these figures:
- Are estimates, which is why Lazard included ranges.
- Only include oral solid generics
- Only include revenues from sales by the entity itself. For example, the figures represent generic sales by a wholesaler, not by the wholesaler’s pharmacy customers.
Lazard’s take:
“As a matter of perspective, however, we don't anticipate that participants in the ABC-WAG/AB buying group will see their cost basis drop so much that it will force such partnering in an accelerated fashion. As shown in the table above, in recent years entities like MCK or CVS have represented materially greater generic purchasing power than a number of their peers — yet the landscape has remained competitive and the playing field seemingly even. How the players use their reduced cost basis represents another important variable as well. Of course lower costs could mean higher profits, reduced pricing to customers, or both. Is more better? Yes. But is it drastically game-changing? We don't think so.”While I'm not a rap fan (shocking, I know), I do see that one of The Notorious B.I.G.'s most famous songs is called "Get Money." The new generic buying combination will surely be following his advice.
Adam, would you think this combo will bring down generic pricing across all classes of trade. Moreover, will lower generic pricing be offset by lower reimbursements. Also, who will buy a generic manufacturer to be vertically integrated?
ReplyDelete